Tirzepatide Tirzepatide, a novel dual agonist of GIP and GLP-1 receptors, has demonstrated exceptional efficacy in improving glycemic control and promoting weight loss in individuals with Type 2 diabetes mellitus (T2DM) and obesity (43)
Despite its significance, the broader functional roles of genes associated with filamentation remain incompletely understood
Research also shows that gastrointestinal symptoms and other side effects are less likely to occur
8 A 2023 meta-analysis 9 demonstrated that consuming just 5 grams of allulose with a carbohydrate-rich meal significantly reduced post-meal blood glucose spikes in healthy adults
Iizuka K, Takao K, Kato T, Horikawa Y, Takeda J
When switching to a less potent alternative, appetite may increase, making mindful eating more important